Emerging nutraceuticals provider Neutra Corp. (OTCBB:NTRR) announced
today that the company has placed its initial order for two new
all-natural male enhancement supplements in order to move forward with
NTRR is working to produce a safe and effective alternative to
prescription male enhancers such as Viagra, which can cause many
unpleasant side effects. Clinical trials will be a crucial step toward
breaking into the multi-billion-dollar sexual enhancement industry.
“The two formulas we’ll be testing contain all-natural ingredients
intended to increase sex drive, boost testosterone levels, support
prostate health and improve circulation,” said NTRR President
Michael-Shane Henderson. “Once the supplements arrive from the
manufacturer, we’ll assemble a clinical testing group and begin studying
their effects in order to fine-tune products that we feel will have the
best chance of breakthrough success in the booming male enhancement
As with its other product offerings under development, NTRR will also
study how Bio-energy infusion could significantly boost the supplements
Neutra Corp. is developing these and other innovative products to
compete in the fast-growing nutraceuticals industry alongside Herbalife
Ltd. (NYSE: HLF), Vitamin Shoppe (NYSE: VSI), Nutraceutical
International Corp. (NASDAQ: NUTR) and Schiff Nutrition International
Inc. (NYSE: WNI).
For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.
Follow NTRR on Twitter at www.twitter.com/neutracorp.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com)
is a healthy lifestyle company that specializes in the development and
marketing of nutritional supplements, nutrient boosters, herbal remedies
and other natural wellness solutions. The company is currently working
to produce a full range of products to address every component of a
healthy lifestyle, including muscle building, weight loss and general
wellness through a daily nutrition regimen. For investing information
and performance data, please visit www.neutracorp.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.